CAMP4 Therapeutics CorporationCAMPNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank36
3Y CAGR+6.8%
5Y CAGR-15.3%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+6.8%/yr
vs -21.8%/yr prior
5Y CAGR
-15.3%/yr
Recent acceleration
Acceleration
+28.5pp
Accelerating
Percentile
P36
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
3 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $54.77M | +1.9% |
| 2024 | $53.74M | +2.9% |
| 2023 | $52.23M | +16.1% |
| 2022 | $45.00M | -66.6% |
| 2021 | $134.76M | +7.1% |
| 2020 | $125.87M | -21.3% |
| 2019 | $159.96M | +33.2% |
| 2018 | $120.05M | -16.0% |
| 2017 | $142.94M | +0.7% |
| 2016 | $142.01M | - |